Expert Interview: Updates in the Management of Chronic Myeloid Leukemia from ASH 2007 -CME
Supportive Care and Hematologic Malignancies: Updates from ASH 2007 -CME
Updates in the Management of Myelodysplastic Syndromes: A Report from ASH 2007 -CME
Advances in the Management of Chronic Myeloid Leukemia: A Report from ASH 2007 -CME
Emerging Strategies in the Treatment of Immune Thrombocytopenic Purpura: A Report from the 2007 American Society of Hematology Meeting -CME
About the Authors

Dr. Hagop M. Kantarjian joined The University of Texas M. D. Anderson Cancer Center in 1981 as a fellow in the Department of Developmental Therapeutics and joined the faculty in 1983. He currently serves as professor of medicine and chairman of the Department of Leukemia, directs the world’s largest comprehensive leukemia program, and holds the Kelcie Margaret Kana Research Chair. | 
Dr. Mikkael A. Sekeres is Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine and staff in the Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, in Ohio. He earned a medical degree and a master’s degree in clinical epidemiology from the University of Pennsylvania School of Medicine. Dr. Sekeres completed his postgraduate training at HarvardUniversity, finishing an internal medicine residency at Massachusetts GeneralHospitaland a fellowship in hematology-oncology at the Dana-Farber Cancer Institute in Boston. He is vice-chair of the medical advisory board of the Aplastic Anemia and Myelodysplastic Syndrome (MDS) International Foundation as well as on the scientific review committee. His current research focuses on patients with MDS and older adults with acute myeloid leukemia. | 
Dr. Abrams is the Associate Professor of Medicine at the University of Pennsylvania Medical Center. He received his B.E.S. degree in Bioengineering from Johns Hopkins University and his medical degree from Yale University School of Medicine. His research interests are focused on molecular and cellular biologic techniques to examine blood cell biology. |
Supporters
The CME portions of the ASH conference coverage are supported by an educational donation from Amgen and educational grants from Novartis and Bristol-Myers Squibb Company.